Skip to main content

Table 6 Incidence of risk factors on cervical disease in HIV infected women under treatment (HAART) and those without treatment or HAART initiation

From: Incidence of cervical disease associated to HPV in human immunodeficiency infected women under highly active antiretroviral therapy

  LSIL HSIL Mann-Withney test
Groups n % Mean ± SE n % Mean ± SE  
Age at first vaginal sex (years)
<15 03 17.6 13.7 ± 0.3 06 27.3 13.2 ± 0.3 0.381 ns
15 – 18 10 58.8 16.5 ± 0.5 11 50.0 16.4 ± 0.3 0.860 ns
≥ 19 04 23.5 19.8 ± 0.5 05 22.7 20.2 ± 0.7 0.905 ns
Total 17 - 16.8 ± 0.5 22 - 16.4 ± 0.6 0.571 ns
Pregnancy
≤ 4 13 76.4 2.4 ± 0.3 10 45.5 2.8 ± 0.3 0.420 ns
5–9 02 11.8 5.5 ± 0.5 10 45.5 1.4 ± 0.4 0.590 ns
≥ 10 02 11.8 11.5 ± 0.5 02 09.0 0.7 ± 0.5 0.333 ns
Total 17 - 3.8 ± 0.8 22 - 5.1 ± 0.6 0.068 ns
Abortion
0 03 17.6 0.0 ± 0.0 06 27.3 0.0 ± 0.0 -
1–2 12 70.6 1.3 ± 0.3 08 36.4 1.4 ± 0.2 0.669 ns
> 2 02 11.7 3.0 ± 0.0 08 36.4 3.6 ± 0.3 0.400 ns
Total 17 - 1.24 ± 0.2 22 - 1.8 ± 0.3 0.372 ns